Dr. Fiandaca is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Asklepios BioPharmaceutical Inc - CNS Gene Therapy
2447 North Star Rd
Upper Arlington, OH 43221Phone+1 510-358-8431
Summary
- Neurosurgeon, neuroscientist, and entrepreneur working in biotechnology company focused on vector-based gene therapy strategies and direct brain delivery technologies for human central nervous system disorders.
Current Specialties: CNS gene therapy; convection enhanced delivery (CED); neurosurgical methods and devices; translational neuroscience research; blood-based biomarkers.
Education & Training
- Loyola University of Maryland, Sellinger School of Business and ManagementMBA, Business and Management, Beta Gamma Sigma, 1999 - 2001
- University of Rochester Medical CenterFellowship, Neurobiology and Anatomy, 1987 - 1988
- Emory University School of MedicineResidency, Neurological Surgery, 1982 - 1987
- Emory University School of MedicineInternship, Surgery, 1981 - 1982
- Oregon Health and Science University School of MedicineClass of 1981, MD, Alpha Omega Alpha
- Oregon State UniversityBS, Zoology, 1973 - 1977
Certifications & Licensure
- CA State Medical License 2016 - 2026
- MD State Medical License 1991 - 2016
- American Board of Neurological Surgery Neurological Surgery
Awards, Honors, & Recognition
- Fellow (FAANS) American Association of Neurological Surgeons
- Fellow (FACS) American College of Surgeons
- Beta Gamma Sigma Loyola University of Maryland, Sellinger School, 2001
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsNew Experimental and Computational Tools for Drug Discovery: From Chemistry to Biology. Metabolomics, Pharmacokinetics, and Medicinal Chemistry. Part - IV.Massimo S. Fiandaca, Raúl González-Domínguez, Humbert González-Díaz
Current Topics in Medicinal Chemistry. 2018-03-31 - 628 citationsIdentification of preclinical Alzheimer's disease by a profile of pathogenic proteins in neurally derived blood exosomes: A case-control studyMassimo S. Fiandaca, Dimitrios Kapogiannis, Mark Mapstone, Adam L. Boxer, Erez Eitan
Alzheimer's & Dementia. 2015-06-01 - 70 citationsDetection of infusate leakage in the brain using real-time imaging of convection-enhanced delivery: Laboratory investigationVanja Varenika, Peter J Dickinson, John Bringas, Richard A Lecouteur, Robert Higgins
Journal of Neurosurgery. 2008-11-01
Journal Articles
- Advancing gene therapies, methods, and technologies for Parkinson's Disease and other neurological disorders.Fiandaca MS, Lonser RR, Elder JB, Zabek M, Bankiewicz KS, Neurol Neurochir Pol., 6/20/2020
- GDNF and Parkinson's Disease: Where Next? A Summary from a Recent WorkshopBarker RA, Bjorklund A, Gash DM, Whone A, Van Laar A, Kordower JH, Bankiewicz K, Kieburtz K, Saarma M, Booms S, Huttunen HJ, Kells A, Fiandaca MS, Stoessl AJ, Eidelber..., J Parkinsons Dis, 6/9/2020
- Author Correction: Plasma microRNA markers of upper limb recovery following human stroke.Edwardson MA, Zhong X, Fiandaca MS, Federoff HJ, Cheema AK, Dromerick AW., Sci Rep., 2/9/2020
Professional Memberships
- Member
- Fellow
- Fellow
- American Society for Cell and Gene Therapy (ASGCT)Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: